Jason Roos, DO
Facial Plastic Surgery · Visalia, CANPI 1205147659
Payments from drug & device makers
What this record shows
16 manufacturers reported payments, led by Medical Device Business Services, Inc. at 59.3% of the total. Reporting peaked in 2020 at $2,109 and has fallen 94.1% since, to $125 in 2025.
Across 69 payments — averaging $65.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$3K
- Acclarent, Inc$608
- GSK$269
- Aerin Medical Inc.$255
- AstraZeneca$150
- Smith+Nephew$117
- plus $438 from 10 others
What the payments were for
- Travel & lodging$2,46555%
- Food & beverage$2,04445%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 9 | $2,673 |
| Acclarent, Inc | 15 | $608 |
| GSK | 12 | $269 |
| Aerin Medical Inc. | 8 | $255 |
| AstraZeneca | 4 | $150 |
| Smith+Nephew | 5 | $117 |
| Amgen | 1 | $108 |
| Stryker | 3 | $89 |
| Medtronic(2 entities) | 4 | $72 |
| Intersect ENT, Inc. | 2 | $48 |
| Arrinex, Inc. | 1 | $31 |
| Neurent Medical Limited | 1 | $25 |
| Johnson & Johnson | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Pfizer | 1 | $15 |
| Sanofi | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,509 in reported general payments places this provider in the 75th percentile of 120 facial plastic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 201 | $5,098 |
| Epinephrine | 11 | $1,880 |
| Fluocinolone Acetonide Oil | 35 | $1,028 |
| Mupirocin | 118 | $712 |
| Omeprazole | 33 | $212 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $128 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $67 |
Paid to pharmacies, not to this prescriber.
Other facial plastic surgery in Visalia
- Daryoush SaadatValencia$1.3M
- Kian KarimiLos Angeles$1.2M
- Rami BatnijiNewport Beach$1M
- Jill HesslerPalo Alto$114K
- Victor LacombeSanta Rosa$106K
- Alen CohenWest Hills$72K
- Bradley GreenePortola Valley$52K
- Geoffrey TrenkleLos Angeles$44K
- Elbert ChengSaratoga$38K
- Benjamin TaleiBeverly Hills$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.